Status:
COMPLETED
Aiming Towards Evidence Based Interpretation of Cardiac Biomarkers in Patients Presenting With Chest Pain Using Point of Care Assays
Lead Sponsor:
Haukeland University Hospital
Collaborating Sponsors:
Siemens Corporation, Corporate Technology
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the current study is to perform a RCT comparing safety and efficiency of a standard care (in-line with current ESC recommendations) to an algorithm that utilize a POC troponin tests for bed...
Detailed Description
Ischemic coronary artery disease is an important health challenge and a common cause of death worldwide. Patients with symptoms suggestive of acute coronary syndrome are frequently referred to the eme...
Eligibility Criteria
Inclusion
- Patients \> 17 years who are referred to the Emergency Department of Haukeland University Hospital with chest pain suspect of ACS
Exclusion
- STEMI (ECG criteria)
- Patients without STEMI who are immediately transferred to cardiac catheterisation lab (due to heart failure, arrhythmia etc.) without possibility for blood sampling
- Patients admitted from Nursing homes
- Patients transferred from other hospitals (e.g. for PCI treatment)
- Less than 2 months life expectancy from comorbid clinical conditions
- Not possible to provide informed consent due to cognitive impairment, language problems or other reasons
Key Trial Info
Start Date :
March 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 26 2024
Estimated Enrollment :
1496 Patients enrolled
Trial Details
Trial ID
NCT05354804
Start Date
March 14 2022
End Date
March 26 2024
Last Update
July 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland University Hospital
Bergen, Norway, 5020